从线粒体角度探讨PARK家族在慢性骨病中的研究进展

    Research Progress on the PARK Family in Chronic Bone Disease Based on the Perspective of Mitochondria

    • 摘要: 线粒体与决定细胞命运的多种生物过程密切相关,能够参与真核生物的氧化代谢、三羧酸循环、能量转化、氧化磷酸化等,其结构及功能的异常是慢性骨病发病的核心环节。研究发现,PARK家族成员能够通过介导线粒体自噬等参与慢性骨病的发生发展过程,但具体分子机制未明。基于此,本文主要总结近年来PARK1PARK2PARK5PARK6PARK7PARK家族成员介导的线粒体自噬、氧化应激、能量代谢在慢性骨病发生发展过程中的分子调控机制研究进展,以期为慢性骨病的临床诊治及靶向治疗提供依据。

       

      Abstract: Mitochondria play a significant role in numerous biological processes that govern cellular destiny, encompassing eukaryotic oxidative metabolism, tricarboxylic acid cycling, energy conversion, and oxidative phosphorylation. Perturbations in their structure and function serve as pivotal factors in chronic bone diseases. Research has indicated that the involvement of PARK family members in mitochondrial autophagy may contribute to the initiation and progression of chronic bone diseases; however, the precise molecular mechanism underlying this association remains elusive. Hence, this review primarily presented a comprehensive overview of the molecular regulatory pathways involving mitochondrial autophagy, oxidative stress, and energy metabolism, which were mediated by PARK family members including PARK1, PARK2, PARK5, PARK6, and PARK7, in the pathogenesis and progression of chronic bone disorders in recent times. in order to furnish substantiated evidence for the clinical diagnosis, treatment, and targeted therapeutic interventions for chronic bone diseases.

       

    /

    返回文章
    返回